Observational studyJournal of primary care & community health
Adult Immunisation in a South Indian Tertiary Care Hospital: Who Benefits, What's Safe, and What Holds Us Back?
Observational study in Journal of primary care & community health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAdult immunisation is a critical yet underutilised public health strategy in India, despite the growing burden of vaccine-preventable diseases (VPDs) among adults. However, previous studies have explored awareness, knowledge, and acceptance of selected adult vaccines, a comprehensive understanding of utilisation patterns and vaccine-seeking behaviour remains limited. METHODOLOGY: A prospective observational study was conducted from April 2023 to February 2024 (10 months) at the Adult Immunisation and Travel Medicine Centre of a tertiary hospital. Adults aged ≥16 years who received at least 1 recommended vaccine were included, focusing on those outside the age group covered by the national immunisation programme. Data on demographics, immunisation status, comorbidities, and adverse events following immunisation (AEFIs) were collected. Statistical associations were analysed using the chi-square test (
resultsA total of 1021 vaccine doses were utilised by 819 individuals. The most commonly utilised vaccines were Hepatitis B (62.03%), Influenza (10.99%), and Pneumococcal Conjugate Vaccine (PCV; 6.72%). The majority of recipients were female (58.97%), young adults (70.7%), healthcare workers (HCWs; 70.69%), and individuals from higher socio-economic classes (61.91%). Vaccine utilisation was 2.4 times higher among HCWs than non-HCWs. Partial immunisation was more common among young males (
conclusionSimilar to global and national trends, adult vaccine coverage remained sub-optimal. However, among the limited users, only the economically advantaged sections of the community were able to afford and access immunisation, while vaccine-seeking behaviour was largely absent across wider segments of society.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.